SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · IEX Real-Time Price · USD
1.520
+0.110 (7.80%)
At close: Apr 18, 2024, 4:00 PM
1.530
+0.010 (0.66%)
After-hours: Apr 18, 2024, 7:59 PM EDT
SLS Market Cap
SLS has a market cap or net worth of $85.53 million as of April 18, 2024. Its market cap has increased by 92.63% in one year.
Market Cap
85.53M
Enterprise Value
82.96M
1-Year Change
92.63%
Ranking
Category
Stock Price
$1.52
Market Cap Chart
Since March 12, 2008, SLS's market cap has decreased from $133.40M to $85.53M, a decrease of -35.89%. That is a compound annual growth rate of -2.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2024 | 79.30M | 3.66% |
| Apr 16, 2024 | 76.50M | 2.27% |
| Apr 15, 2024 | 74.80M | -0.80% |
| Apr 12, 2024 | 75.40M | -4.31% |
| Apr 11, 2024 | 78.80M | 0.77% |
| Apr 10, 2024 | 78.20M | -0.76% |
| Apr 9, 2024 | 78.80M | -3.08% |
| Apr 8, 2024 | 81.30M | 7.82% |
| Apr 5, 2024 | 75.40M | 3.86% |
| Apr 4, 2024 | 72.60M | -1.49% |
| Apr 3, 2024 | 73.70M | 10.99% |
| Apr 2, 2024 | 66.40M | 10.30% |
| Apr 1, 2024 | 60.20M | 5.99% |
| Mar 28, 2024 | 56.80M | 72.12% |
| Mar 27, 2024 | 33.00M | -2.94% |
| Mar 26, 2024 | 34.00M | 2.10% |
| Mar 25, 2024 | 33.30M | -2.92% |
| Mar 22, 2024 | 34.30M | 5.86% |
| Mar 21, 2024 | 32.40M | -2.70% |
| Mar 20, 2024 | 33.30M | -1.19% |
| Mar 19, 2024 | 33.70M | - |
| Mar 18, 2024 | 33.70M | -4.53% |
| Mar 15, 2024 | 35.30M | -28.97% |
| Mar 14, 2024 | 49.70M | 3.97% |
| Mar 13, 2024 | 47.80M | 8.14% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Forian | 85.46M |
| Reviva Pharmaceuticals Holdings | 84.18M |
| AlloVir | 83.84M |
| PMV Pharmaceuticals | 83.34M |
| Protalix BioTherapeutics | 83.28M |
| Connect Biopharma Holdings | 83.21M |
| CEL-SCI | 83.13M |
| Spero Therapeutics | 81.88M |